Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenit...
Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease
About this item
Full title
Author / Creator
Publisher
New York: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
The objective of this study was to evaluate the impact of palivizumab prophylaxis on respiratory syncytial virus (RSV) hospitalizations among children with hemodynamically significant congenital heart disease (CHD). In 2003, the American Academy of Pediatrics (AAP) revised the bronchiolitis policy statement and recommended the use of palivizumab in...
Alternative Titles
Full title
Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2807022
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2807022
Other Identifiers
ISSN
0172-0643,1432-1971
E-ISSN
1432-1971
DOI
10.1007/s00246-009-9577-0
